-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At the beginning of the outbreak, Ling Pharmaceuticals put forward a "tight and orderly, busy and not disorderly, layer-by-layer control, ensure quality" production policy, the first time to adjust all production lines for lianhua Qing plague, even flowering plague production capacity from 38 million capsules per day to 53 million capsules, 2 million bags of particles, a day to meet the 700,000 people a week of dosed.
The prospective, randomized, controlled and multi-center clinical study of the treatment of new coronavirus pneumonia by Chinese medicine Lianhua Qing plague capsules", which was jointly participated by Zhong Nanshan academician and other experts in more than 20 hospitals, was published in the journal Plant Medicine, which has a higher influence factor in the field of international botany medicine.
The study found that the treatment of new coronavirus pneumonia on the basis of conventional treatment was safe and effective, which could significantly improve the clinical symptoms and clinical outcomes of patients with new coronavirus pneumonia.
White Paper of the Information Office of the State Council on China's Action to Combat the Outbreak of New Crown Pneumonia clearly states that the clinical efficacy of Chinese medicine, represented by the "three-way three-peddle" such as Lianhua Qing plague, is accurate.
the outbreak, we are the community of destiny, but also the community of responsibility.
Pharmaceuticals has donated nearly 20 million yuan worth of anti-epidemic drugs and cash to domestic and foreign countries.
On the morning of October 15th, Erling Pharmaceuticals donated 12,000 boxes of lianhua qing plague particles to the Qingdao Red Cross for the prevention and control of new crown pneumonia by medical staff and residents of six hospitals in Qingdao.
Since the outbreak, Toling Pharmaceuticals has also accelerated the international registration process of Lianhua Qing plague, has been listed in Singapore, Thailand, Romania and other nearly 20 countries and regions, and at the same time in the Middle East, Africa, Latin America and other 30 countries to start registration work, Chinese medicine hard nuclear disease resistance, "Lianhua" at home and abroad "clear plague."
It is reported that Ling Pharmaceuticals, as a national pharmaceutical enterprise, will further develop its research and development and production advantages, pass on the essence, keep the innovation, promote the revitalization and development of Chinese medicine, promote the modernization and internationalization of Chinese medicine, and play a greater role in promoting healthy China and achieve greater development.
.